Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

NCT00907998 ·Status: COMPLETED ·Phase: PHASE1

Desflurane-induced Myocardial Protection

NCT02019797 ·Status: UNKNOWN ·Phase: PHASE4

Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure

NCT03590522 ·Status: UNKNOWN

An Exploratory Study of Nesiritide in Participants With Acute Heart Failure

NCT00490724 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

NCT05724121 ·Status: RECRUITING

Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

NCT06280768 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy

NCT00842023 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

NCT03508271 ·Status: COMPLETED

Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention

NCT06463808 ·Status: RECRUITING

Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure

NCT03016325 ·Status: COMPLETED ·Phase: PHASE2

An Interaction Study With Digoxin and AZD1305

NCT00712465 ·Status: COMPLETED ·Phase: PHASE1

Prevention of Anthracycline-induced Cardiotoxicity

NCT01968200 ·Status: UNKNOWN ·Phase: PHASE3

Detection of Chemotherapy Induced Cardiotoxicity

NCT00636844 ·Status: COMPLETED

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

NCT01264783 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure

NCT00091520 ·Status: COMPLETED ·Phase: PHASE2

Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)

NCT01370629 ·Status: COMPLETED

Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences

NCT00128453 ·Status: COMPLETED ·Phase: PHASE3

Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy

NCT00443690 ·Status: COMPLETED ·Phase: PHASE3

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

NCT03357731 ·Status: COMPLETED ·Phase: PHASE2

An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

NCT00813202 ·Status: COMPLETED ·Phase: PHASE3

To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women

NCT04281342 ·Status: COMPLETED ·Phase: PHASE1

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

NCT03285373 ·Status: COMPLETED

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

NCT04426084 ·Status: UNKNOWN

A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure

NCT01120210 ·Status: COMPLETED ·Phase: PHASE2

Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103

NCT02390258 ·Status: COMPLETED ·Phase: PHASE1